Analysis of prognosis on patients with severe viral hepatitis using the model for end-stage liver disease

Table 3 Changes in related data of the PE group between before and after the plasma exchange (mean±SD).

	20 ≤MELD<30		30 ≤MELD<40		MELD≥40
	Before PE	After PE	Before PE	After PE	Before PE	After PE
Bilirubin (mmol/L)	561.66±148.92	242.01±134.39b	606.40±150.60	260.85±64.65b	600.77±140.90	289.70±147.50b
INR	2.13±0.62	1.55±0.28a	3.54±1.16	1.59±0.22a	4.01±1.58	2.40±1.52a
Creatinine (mmol/L)	70.53±18.68	88.00±21.28	106.45±37.31	124.78±41.22	237.12±136.64	228.38±132.04
MELD score	24.7±3.1	19.7±3.5 a	34.7±2.2	22.7±3.7a	42.7±1.7	28.4±5.3a

^aP<0.05, after PE vs before PE;

^bP<0.01, after PE vs before PE.